Skyline of Las Vegas
Real news. Real stories. Real voices.
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
Supported by

GLP-1s: What you need to know

Boxes for the medications Wegovy and Zepbound are arranged for a photograph in California, May 8, 2025. (JoNel Aleccia/AP)
JoNel Aleccia/AP
Boxes for the medications Wegovy and Zepbound are arranged for a photograph in California, May 8, 2025. (JoNel Aleccia/AP)

It’s impossible to avoid headlines about GLP-1 medications. The weight-loss drugs target hormones in the gut and brain that affect appetite and feelings of fullness.

For some people with obesity, the medications have been life-changing. For others, the cost of these drugs makes taking them impossible.

Dr. Jorge Moreno, an obesity specialist a Yale Medicine, joins Here & Now to discuss accessibility to GLP-1s.

This article was originally published on WBUR.org.

Copyright 2025 WBUR

Tags
Here & Now Newsroom
Sink your teeth into our annual collection of dining — and drinking — stories, including a tally of Sin City's Tiki bars, why good bread is having a moment, and how one award-winning chef is serving up Caribbean history lessons through steak. Plus, discover how Las Vegas is a sports town, in more ways than one. Bon appétit!